« Back to Record
Citation APA

Turner, N. C., Balmaña, J., Poncet, C., Goulioti, T., Tryfonidis, K., Honkoop, A. A., Zoppoli, G., Razis, E., Johannsson, O. T., Colleoni, M. A., Tutt, A. M., Audeh, W., Ignatiadis, M., Mailliez, A., Tredan, O., Musolino, A., Vuylsteke, P., Juan-Fita, M. J., Macpherson, I. R. J., Kaufman, B., Manso, L., Goldstein, L. L., Ellard, S. S., Láng, I., Jen, K. Y., Adam, V., Litière, S., Erban, J., & Cameron, D. A. (2021). Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: The EORTC 1307-BCG/ BIG5–13/TESARO PR-30–50–10-C BRAVO Study. Clinical cancer research, 27(20), 5482-5491. doi:10.1158/1078-0432.CCR-21-0310


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/333689

Turner, N. C., Balmaña, J., Poncet, C., Goulioti, T., Tryfonidis, K., Honkoop, A. A., Zoppoli, G., Razis, E., Johannsson, O. T., Colleoni, M. A., Tutt, A. M., Audeh, W., Ignatiadis, M., Mailliez, A., Tredan, O., Musolino, A., Vuylsteke, P., Juan-Fita, M. J., Macpherson, I. R. J., Kaufman, B., Manso, L., Goldstein, L. L., Ellard, S. S., Láng, I., Jen, K. Y., Adam, V., Litière, S., Erban, J., & Cameron, D. A. (2021). Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: The EORTC 1307-BCG/ BIG5–13/TESARO PR-30–50–10-C BRAVO Study. Clinical cancer research, 27(20), 5482-5491. doi:10.1158/1078-0432.CCR-21-0310